Literature DB >> 17496287

Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

Visanu Thamlikitkul, Surapee Tiengrim, Chanwit Tribuddharat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17496287     DOI： 10.1093/jac/dkm142

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Investigation of in-vitro susceptibility of multidrug-resistant Acinetobacter baumannii strains isolated from clinical specimens to tigecycline.

Authors:  Tekin Tas; Esra Kocoglu; Zafer Mengeloglu; Ozlem Bucak; Seyda Karabörk
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

Review 2.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 3.  Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.

Authors:  Drosos E Karageorgopoulos; Theodore Kelesidis; Iosif Kelesidis; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2008-04-24       Impact factor: 5.790

4.  Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.

Authors:  Visanu Thamlikitkul; Surapee Tiengrim
Journal:  J Antimicrob Chemother       Date:  2008-06-21       Impact factor: 5.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.